Edition:
United Kingdom

Cara Therapeutics Inc (CARA.OQ)

CARA.OQ on NASDAQ Stock Exchange Global Market

18.91USD
9:00pm BST
Change (% chg)

$1.21 (+6.84%)
Prev Close
$17.70
Open
$17.75
Day's High
$19.15
Day's Low
$17.75
Volume
242,556
Avg. Vol
209,180
52-wk High
$24.30
52-wk Low
$11.50

About

Cara Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing chemical entities designed to alleviate pain and pruritus by focusing on kappa opioid receptors. It is developing a class of product candidates that target the body's peripheral nervous system. The... (more)

Overall

Beta: 3.11
Market Cap(Mil.): $444.74
Shares Outstanding(Mil.): 32.58
Dividend: --
Yield (%): --

Financials

  CARA.OQ Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -2.33 -- --
ROI: -66.80 8.91 13.83
ROE: -67.79 10.06 15.25

Earnings vs. Estimates